Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform
Jonas Willmann(Memorial Sloan Kettering Cancer Center), Nicolaus Andratschke(University Hospital of Zurich), Stephanie Tandini-Lang(University of Zurich), N. Reynaert(Institut Jules Bordet), Carsten Nieder(Nordland Hospital Trust), Panagiotis Balermpas(University of Zurich), Maximilian Niyazi(German Cancer Research Center), Coen Hurkmans(Radboud University Nijmegen), Brigitta G. Baumert(Kantonsspital Graubünden), Ane Appelt(University of Leeds), Orit Kaidar‐Person(Dana-Farber Cancer Institute), Morten Høyer(Aarhus University Hospital), Icro Meattini(Azienda Ospedaliero-Universitaria Careggi), Yvette M. van der Linden(Leiden University Medical Center), Dirk De Ruysscher(Maastricht University Medical Centre), Philip Poortmans(University of Antwerp)
Cited by 72
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k